Építés alatt – nem éles oldal
Belépés

What researchers published on IgA-nefropátia

4637 papers, newest first.

Showing 20 of 4637

  • EsetismertetésNephrotic Syndrome as the Initial Presentation of IgA Nephropathy: A Case Report.Cureus
  • Challenges in Predicting Estimated Glomerular Filtration Rate Slope Among Adult Patients With IgA Nephropathy: A Population-Based Cohort Study.Canadian journal of kidney health and disease
  • Corrigendum to Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy.The Journal of clinical investigation
  • Áttekintés[IgA nephropathy: mucosal immune dysregulation in the terminal ileum and the multi-hit hypothesis].Zhonghua nei ke za zhi
  • Dynamic sample augmentation discovers gene biomarker for IgA nephropathy.Journal of biological engineering
  • External validation of the International IgA Nephropathy Prediction Tool in Chinese patients: assessing model performance and the impact of crescents.International urology and nephrology
  • Clinical Trial of Open-Label Mezagitamab in IgAN: Final 96-Week Results.Kidney international reports
  • Glomerular C4d Deposition and Persistent Proteinuria in IgA Nephropathy: A Longitudinal Cohort Study.Journal of clinical medicine
  • EsetismertetésPortal vein thrombosis following targeted-release budesonide in IgA nephropathy and occult liver disease.Clinical kidney journal
  • Peripheral neutrophil count and kidney outcomes in IgA nephropathy: a retrospective cohort study of 9,030 patients.Frontiers in immunology
  • Mechanisms Behind the Disease: Understanding the Role of APRIL in IgAN Pathogenesis: A Podcast.Advances in therapy
  • Efficacy and safety of ambrisentan in IgA nephropathy: real-world evidence.Frontiers in immunology
  • Evaluating the Long-Term Risk of Kidney Failure in IgAN Using a Real-World Population-Level Cohort From Canada.Kidney international reports
  • ÁttekintésRole of the complement system in normocomplementemic glomerulopathies.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • IKK-β inhibitor TPCA-1 increases Gd-IgA1 production and decreases C1GALT1 expression in EBV-immortalized B cells from human donors.Frontiers in immunology
  • Iptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
  • Iptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
  • Iptacopan in IgA Nephropathy - Final 24-Month Data. Reply.The New England journal of medicine
  • Iptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
  • Clinical significance of the systemic immune-inflammation index as a minimally invasive biomarker reflecting histological activity in IgA nephropathy.Renal failure